Press/Media
- 1 - 25 out of 26 results
Search results
-
3 Psychedelic Stocks for Potential Out-of-This-World Gains
18/11/21
2 items of Media coverage
Press/Media: Public Engagement › Popular
-
Alles kan tijdens festival over psychedelische drugs in Heerlen, behalve ze gebruiken
20/01/23
1 Media contribution
Press/Media: Expert Comment › Popular
-
-
De toekomst van medicinale mdma ziet er in Nederland veelbelovend uit
18/11/21
1 item of Media coverage
Press/Media: Public Engagement › Popular
-
Form 6-K Mind Medicine (MindMed) For: Nov 12
12/11/21
1 item of Media coverage
Press/Media: Public Engagement › Popular
-
Form 6-K Mind Medicine (MindMed) For: Nov 16
16/11/21
1 item of Media coverage
Press/Media: Public Engagement › Popular
-
If you want psychedelic healing, your ego may need to die
10/01/23
1 Media contribution
Press/Media: Expert Comment › Popular
-
Intranasal Ketamine Garnering A lot of Attention as an Effective Treatment For Depression
22/11/21 → 24/11/21
62 items of Media coverage
Press/Media: Public Engagement › Popular
-
Lachgas minstens een uur lang aantoonbaar in bloed en adem, blijkt uit onderzoek Universiteit Maastricht
19/02/24
1 Media contribution
Press/Media: Expert Comment › Popular
-
Meer mentaal welzijn met een microdosis psychedelica bij het ontbijt?
12/01/24
1 Media contribution
Press/Media: Expert Comment › Popular
-
Microdosering: word je door kleine porties hallucinerende drugs een betere versie van jezelf? ‘Je doet alles met een bepaalde focus’
14/03/23
1 Media contribution
Press/Media: Expert Comment › Popular
-
Mind Medicine begins recruitment for LSD sleep study
16/11/21
1 item of Media coverage
Press/Media: Public Engagement › Popular
-
Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) to C
16/12/21
1 item of Media coverage
Press/Media: Research › Popular
-
MindMed Initiates Phase 2a LSD Trial for the Treatment of Adult ADHD
2/11/21 → 20/12/21
186 items of Media coverage
Press/Media: Research › Popular
-
MindMed Launches Study of Low-Dose LSD Effects on Sleep and Cognitive Measures
16/11/21
2 items of Media coverage
Press/Media: Public Engagement › Popular
-
MindMed Launches Study of Low-Dose LSD Effects on Sleep and Cognitive Measures
16/11/21
63 items of Media coverage
Press/Media: Public Engagement › Popular
-
MindMed Q3 Earnings: Big Improvement, Kicks Off Sleep & Cognitive Study With Dose Low-Dose LSD
16/11/21
2 items of Media coverage
Press/Media: Public Engagement › Popular
-
New Study of Ayahuasca Users Shows Placebo Effect in Action
Malin Uthaug
29/11/21
1 item of Media coverage
Press/Media: Public Engagement › Popular
-
Nog even en we trippen onze trauma's weg
24/11/21
1 item of Media coverage
Press/Media: Public Engagement › Popular
-
Podcast DOCS #108 : De Tripgeneratie
18/01/23
1 Media contribution
Press/Media: Expert Comment › Popular
-
Potential $3 Trillion Healthcare Tech Transformation Underway
16/12/21
2 items of Media coverage
Press/Media: Research › Popular
-
-
Study Finds Hallucinogenic Ayahuasca Tea Trip Matches That of Placebo
Malin Uthaug
1/12/21
1 item of Media coverage
Press/Media: Research › Popular
-
Waarom onderzoeker Kim Kuyper razend enthousiast is over de inzet van partydrugs in de ggz
22/03/23
1 Media contribution
Press/Media: Expert Comment › Popular
-
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
22/11/21
2 items of Media coverage
Press/Media: Public Engagement › Popular